After rebranding, Cambridge biotech Astria licenses dermatitis drug for $320M
Just over two years after it rebranded as an allergy and immunology company, Astria Therapeutics is adding a second drug to its clinical pipeline through a $320 million deal with another company. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 16, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
Mixed Findings on Link Between Eczema and Neuropsychiatric Conditions
(MedPage Today) -- Adults with atopic dermatitis (AD) had a significantly higher prevalence of anxiety, depression, and obsessive-compulsive disorder (OCD) across all severities of the skin disorder, a large retrospective analysis showed.
The... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 12, 2023 Category: Psychiatry Source Type: news
Atopic Dermatitis: 5 Things to Know Atopic Dermatitis: 5 Things to Know
From subtle differences in presentation to diagnostic pearls and the newest and emerging treatments, check out these 5 things to know about atopic dermatitis.Medscape Dermatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 11, 2023 Category: Allergy & Immunology Tags: Dermatology Commentary Source Type: news
FDA Issues Letter Regarding Lebrikizumab Review for AD FDA Issues Letter Regarding Lebrikizumab Review for AD
The FDA has issued a complete response letter regarding lebrikizumab, an investigational biologic for the treatment of adult and adolescent patients with moderate to severe atopic dermatitis.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news
Children With Eczema More Likely to Have Allergic Contact Dermatitis
MONDAY, Oct. 2, 2023 -- Children with atopic dermatitis (AD) are more likely to have positive patch test (PPT) reactions, according to a study published online Sept. 25 in the Journal of the American Academy of Dermatology.
Hadley Johnson, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 2, 2023 Category: Pharmaceuticals Source Type: news
Kids With Eczema May Need Further Allergy Tests
FRIDAY, Sept. 29, 2023 -- Some children who have a common form of eczema should also be tested for allergic reactions because they may have a second allergic-type eczema, a new study suggests.
While atopic dermatitis is common and usually develops... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 29, 2023 Category: General Medicine Source Type: news
Study Finds IBD Risk Higher in Children, Adults with AD Study Finds IBD Risk Higher in Children, Adults with AD
Children and adults with atopic dermatitis may be at increased risk for inflammatory bowel disease, researchers report.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 29, 2023 Category: Internal Medicine Tags: Dermatology News Source Type: news
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
TUESDAY, Sept. 26, 2023 -- For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published online Sept. 19 in the British Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 26, 2023 Category: Pharmaceuticals Source Type: news
60% Of Sun Screens Would Fail Federal Safety Tests!
Here in South Florida, spring break is in full swing.
Temperatures are in the mid-to-high-80s, and tourists are flocking to our beautiful, sunny beaches.
Of course, that also means it’s prime time for sunscreen companies to kick up their marketing efforts in an attempt to whip up more fear over the sun.
They want to scare you into thinking that each time the sun strikes your unprotected skin, you risk malignant melanoma, the deadliest form of skin cancer.
If you’re a regular reader, you know that I’ve been vocal about Big Retail’s money grab and how they put out misinformation because they profit each time you slat...
Source: Al Sears, MD Natural Remedies - September 19, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Source Type: news
CHMP Recommends Marketing of Biologic for Atopic Dermatitis CHMP Recommends Marketing of Biologic for Atopic Dermatitis
Lebrikizumab is a monoclonal antibody that binds to cytokine IL-13, which has been implicated in driving the type-2 inflammatory loop in the skin, leading to skin barrier dysfunction.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 16, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Atopic Dermatitis: The Importance of Treatment Adherence
Atopic dermatitis can be unpredictable, but it’s important to stick with treatment, even when your skin is clear. These five strategies can help with treatment adherence. (Source: WebMD Health)
Source: WebMD Health - September 13, 2023 Category: Consumer Health News Source Type: news
Meta-Analysis Points to Most Effective Topical Treatments for Atopic Dermatitis
(MedPage Today) -- Pimecrolimus, tacrolimus, and moderate-potency topical corticosteroids (TCS) are the most effective in the treatment of atopic dermatitis (AD), according to a systematic review and meta-analysis.
High-certainty evidence showed... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - September 8, 2023 Category: Allergy & Immunology Source Type: news
Utilization of Topical Ruxolitinib in Dermatology Utilization of Topical Ruxolitinib in Dermatology
This review summarizes the use of topical ruxolitinib, a JAK inhibitor, in various dermatological conditions including vitiligo, alopecia areata, atopic dermatitis, psoriasis, and more.Skin Therapy Letter (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 4, 2023 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
Atopic Dermatitis Increases Risk for Inflammatory Bowel Disease
THURSDAY, Aug. 31, 2023 -- Both children and adults with atopic dermatitis have an increased risk for inflammatory bowel disease (IBD), according to a study published online Aug. 30 in JAMA Dermatology.
Zelma C. Chiesa Fuxench, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 31, 2023 Category: Pharmaceuticals Source Type: news
Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kids
(MedPage Today) -- Both children and adults with atopic dermatitis have an increased risk of inflammatory bowel disease (IBD), according to a population-based cohort study.
In fully adjusted models, kids with atopic dermatitis had a 44% increased... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 30, 2023 Category: Gastroenterology Source Type: news
